Brain Tumor Reports
48

Volume 19 Number 9
September 2017


Home > Publications > Brain Tumor Reports > Volume 19, Year 2017 > Number 9, September


CONTENTS



BRAIN TUMORS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
- Anaplastic astrocytoma
- Glioblastoma

OTHER ASTROCYTIC TUMORS
- Pilocytic astrocytoma
--- Pilomyxoid astrocytoma

EPENDYMAL TUMORS
- Ependymoma

GLIOMAS
- Brain stem gliomas
--- Diffuse intrinsic pontine gliomas
- High-grade gliomas

EMBRYONAL TUMORS
- Medulloblastoma





BRAIN TUMORS



Levin VA, Abrey LE, Heffron TP, Tonge PJ, Dar AC, Weiss WA, Gallo JM.
CNS Anticancer Drug Discovery and Development: 2016 conference insights.
CNS Oncol. 2017 Jul 18. doi: 10.2217/cns-2017-0014. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Politsky JM.
Brain Tumor-Related Epilepsy: a Current Review of the Etiologic Basis and Diagnostic and Treatment Approaches.
Curr Neurol Neurosci Rep. 2017 Sep;17(9):70. doi: 10.1007/s11910-017-0777-3.
Source | Abstract | Full text | Similar articles





DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



ANAPLASTIC ASTROCYTOMA


Schiff D.
Benefit with adjuvant chemotherapy in anaplastic astrocytoma.
Lancet. 2017 Aug 8. pii: S0140-6736(17)31477-0. doi: 10.1016/S0140-6736(17)31477-0. [Epub ahead of print]
Comment on: van den Bent MJ et al, Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
Source | Abstract | Full text | Similar articles




van den Bent MJ, Baumert B, Erridge SC, Vogelbaum MA, Nowak AK, Sanson M, Brandes AA, Clement PM, Baurain JF, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Brachman DG, Taal W, Rudà R, Weller M, McBain C, Reijneveld J, Enting RH, Weber DC, Lesimple T, Clenton S, Gijtenbeek A, Pascoe S, Herrlinger U, Hau P, Dhermain F, van Heuvel I, Stupp R, Aldape K, Jenkins RB, Dubbink HJ, Dinjens WNM, Wesseling P, Nuyens S, Golfinopoulos V, Gorlia T, Wick W, Kros JM.
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
Lancet. 2017 Aug 8. pii: S0140-6736(17)31442-3. doi: 10.1016/S0140-6736(17)31442-3. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zhou Z, Howard TA, Villano JL.
Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma.
Cancer Chemother Pharmacol. 2017 Aug 8. doi: 10.1007/s00280-017-3415-5. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




GLIOBLASTOMA


Behmanesh B, Setzer M, Konczalla J, Harter P, Quick-Weller J, Imoehl L, Franz K, Gessler F, Seifert V, Marquardt G.
Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.
World Neurosurg. 2017 Feb;98:198-202. doi: 10.1016/j.wneu.2016.10.075. Epub 2016 Oct 21.
Source | Abstract | Full text | Similar articles




Chiang S.
Follow-Up Imaging: Molecular Imaging is Likely Best as a Single Modality, but Multimodality Imaging is the Future.
Front Neurol. 2015 Apr 24;6:74. doi: 10.3389/fneur.2015.00074. eCollection 2015. Review. No abstract available.
Source | Abstract | Full text | Similar articles




Galldiks N, Langen KJ.
Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
Front Neurol. 2016 Jul 28;7:120. doi: 10.3389/fneur.2016.00120. eCollection 2016.
Source | Abstract | Full text | Similar articles




Huang RY, Neagu MR, Reardon DA, Wen PY.
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.
Front Neurol. 2015 Feb 23;6:33. doi: 10.3389/fneur.2015.00033. eCollection 2015.
Source | Abstract | Full text | Similar articles




Lewis GD, Rivera AL, Tremont-Lukats IW, Ballester-Fuentes LY, Zhang YJ, Teh BS.
GBM skin metastasis: a case report and review of the literature.
CNS Oncol. 2017 Jul 18. doi: 10.2217/cns-2016-0042. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Liljehult MM, Buus L, Liljehult J, Rasmussen BK.
Walking ability in patients with glioblastoma: prognostic value of the Berg Balance Scale and the 10 meter walk test.
J Neurooncol. 2017 Jul 27. doi: 10.1007/s11060-017-2579-5. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




New PZ, Rosenfeld MR.
Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy-Detecting Elusive Disease, Defining Response.
Front Neurol. 2017 Jul 3;8:311. doi: 10.3389/fneur.2017.00311. eCollection 2017.
Source | Abstract | Full text | Similar articles




Prasad GL.
Primary Spinal Cord Glioblastoma Multiforme: A Rare but Uniformly Fatal Neoplasm.
World Neurosurg. 2017 Aug;104:1020-1021. doi: 10.1016/j.wneu.2017.02.125.
Source | Abstract | Full text | Similar articles




Tipping M, Eickhoff J, Ian Robins H.
Clinical outcomes in recurrent glioblastoma with bevacizumab therapy: An analysis of the literature.
J Clin Neurosci. 2017 Oct;44:101-106. doi: 10.1016/j.jocn.2017.06.070. Epub 2017 Jul 12.
Source | Abstract | Full text | Similar articles




van Linde ME, Brahm CG, de Witt Hamer PC, Reijneveld JC, Bruynzeel AME, Vandertop WP, van de Ven PM, Wagemakers M, van der Weide HL, Enting RH, Walenkamp AME, Verheul HMW.
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis.
J Neurooncol. 2017 Jul 20. doi: 10.1007/s11060-017-2564-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wong KK, Fung SH, New PZ, Wong ST.
Technical Pitfalls of Signal Truncation in Perfusion MRI of Glioblastoma.
Front Neurol. 2016 Aug 2;7:121. doi: 10.3389/fneur.2016.00121. eCollection 2016.
Source | Abstract | Full text | Similar articles





OTHER ASTROCYTIC TUMORS



PILOCYTIC ASTROCYTOMA


Pilomyxoid astrocytoma


He J, Li X, Zhu W, Li C, Gong J.
Posterior fossa pilomyxoid astrocytoma with spontaneous hemorrhage in pediatric patients.
Childs Nerv Syst. 2017 Jul 24. doi: 10.1007/s00381-017-3549-0. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





EPENDYMAL TUMORS



EPENDYMOMA


Marinoff AE, Ma C, Guo D, Snuderl M, Wright KD, Manley PE, Al-Sayegh H, Sinai CE, Ullrich NJ, Marcus K, Haas-Kogan D, Goumnerova L, London WB, Kieran MW, Chi SN, Fangusaro J, Bandopadhayay P.
Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.
J Neurooncol. 2017 Jul 21. doi: 10.1007/s11060-017-2568-8. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





GLIOMAS



Gu J, Lu Z, Ji C, Chen Y, Liu Y, Lei Z, Wang L, Zhang HT, Li X.
Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells.
Biomed Pharmacother. 2017 Sep;93:969-975. doi: 10.1016/j.biopha.2017.07.010. Epub 2017 Jul 14.
Source | Abstract | Full text | Similar articles




Mesfin F, Al-Dhahir M.
Cancer, Brain, Gliomas.
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.2017 Jul 15.
Source | Abstract | Full text | Similar articles




BRAIN STEM GLIOMAS


Quick-Weller J, Tritt S, Behmanesh B, Mittelbronn M, Spyrantis A, Dinc N, Weise L, Seifert V, Marquardt G, Freiman TM.
Biopsies of pediatric brainstem lesions display low morbidity but strong impact on further treatment decisions.
J Clin Neurosci. 2017 Oct;44:254-259. doi: 10.1016/j.jocn.2017.06.028. Epub 2017 Jul 12.
Source | Abstract | Full text | Similar articles




Diffuse intrinsic pontine gliomas


Long W, Yi Y, Chen S, Cao Q, Zhao W, Liu Q.
Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma.
Front Pharmacol. 2017 Jul 25;8:495. doi: 10.3389/fphar.2017.00495. eCollection 2017.
Source | Abstract | Full text | Similar articles




Veldhuijzen van Zanten SEM, El-Khouly FE, Jansen MHA, Bakker DP, Sanchez Aliaga E, Haasbeek CJA, Wolf NI, Zwaan CM, Vandertop WP, van Vuurden DG, Kaspers GJL.
A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.
J Neurooncol. 2017 Jul 26. doi: 10.1007/s11060-017-2575-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




HIGH-GRADE GLIOMAS


Galante JR, Rodriguez F, Grossman SA, Strowd RE.
Late post-treatment radiographic changes 3 years following chemoradiation for glioma: the importance of histopathology.
CNS Oncol. 2017 Jul 18. doi: 10.2217/cns-2016-0040. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Nathan JK, Brezzell AL, Kim MM, Leung D, Wilkinson DA, Hervey-Jumper SL.
Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma.
J Neurooncol. 2017 Jul 25. doi: 10.1007/s11060-017-2577-7. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Parasramka S, Talari G, Rosenfeld M, Guo J, Villano JL.
Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Cochrane Database Syst Rev. 2017 Jul 26;7:CD011773. doi: 10.1002/14651858.CD011773.pub2.
Source | Abstract | Full text | Similar articles





EMBRYONAL TUMORS



MEDULLOBLASTOMA


Gupta T, Dasgupta A, Epari S, Shirsat N, Chinnaswamy G, Jalali R.
Extraneuraxial metastases in medulloblastoma: is histology and molecular biology important?
J Neurooncol. 2017 Jul 28. doi: 10.1007/s11060-017-2586-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, Waszak SM, Erkek S, Jones DTW, Worst BC, Kool M, Zapatka M, Jäger N, Chavez L, Hutter B, Bieg M, Paramasivam N, Heinold M, Gu Z, Ishaque N, Jäger-Schmidt C, Imbusch CD, Jugold A, Hübschmann D, Risch T, Amstislavskiy V, Gonzalez FGR, Weber UD, Wolf S, Robinson GW, Zhou X, Wu G, Finkelstein D, Liu Y, Cavalli FMG, Luu B, Ramaswamy V, Wu X, Koster J, Ryzhova M, Cho YJ, Pomeroy SL, Herold-Mende C, Schuhmann M, Ebinger M, Liau LM, Mora J, McLendon RE, Jabado N, Kumabe T, Chuah E, Ma Y, Moore RA, Mungall AJ, Mungall KL, Thiessen N, Tse K, Wong T, Jones SJM, Witt O, Milde T, Von Deimling A, Capper D, Korshunov A, Yaspo ML, Kriwacki R, Gajjar A, Zhang J, Beroukhim R, Fraenkel E, Korbel JO, Brors B, Schlesner M, Eils R, Marra MA, Pfister SM, Taylor MD, Lichter P.
The whole-genome landscape of medulloblastoma subtypes.
Nature. 2017 Jul 19;547(7663):311-317. doi: 10.1038/nature22973.
Source | Abstract | Full text | Similar articles




Sengupta S, Pomeranz Krummel D, Pomeroy S.
The evolution of medulloblastoma therapy to personalized medicine.
F1000Res. 2017 Apr 13;6:490. doi: 10.12688/f1000research.10859.1. eCollection 2017.
Source | Abstract | Full text | Similar articles




Veneroni L, Boschetti L, Barretta F, Clerici CA, Simonetti F, Schiavello E, Biassoni V, Spreafico F, Gandola L, Pecori E, Diletto B, Poggi G, Gariboldi F, Sensi R, Massimino M.
Quality of life in long-term survivors treated for metastatic medulloblastoma with a hyperfractionated accelerated radiotherapy (HART) strategy.
Childs Nerv Syst. 2017 Aug 2. doi: 10.1007/s00381-017-3548-1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles